Back to Search
MITCHELL SADAR, PH.D.
PH.D.
Cognitive & Behavioral Psychologist
NPI: 1588607196IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cognitive & Behavioral PsychologistPrimary
Psychologist — Cognitive & Behavioral
Code: 103TB0200X
PS-004097L(PA)
CMS Specialties
PrimaryCLINICAL PSYCHOLOGIST
Education
OTHER
Class of 1983
Research & Publications (20)
Characterization of a new in vivo hollow fiber model for the study of progression of prostate cancer to androgen independence.
PMID 12479223·Mol Cancer Ther·2002
7-preclinical
Regulation of cytochrome P450 in a primary culture of rainbow trout hepatocytes.
PMID 11370812·In Vitro Cell Dev Biol Anim·2001
7-preclinical
Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells.
PMID 11059779·Cancer Res·2000
7-preclinical
Connective tissue-activating peptide III: a novel blood biomarker for early lung cancer detection.
PMID 19414677·J Clin Oncol·2009
8-other
Osteoblast-derived factors induce an expression signature that identifies prostate cancer metastasis and hormonal progression.
PMID 19351846·Cancer Res·2009
7-preclinical
Crosstalk between the androgen receptor and beta-catenin in castrate-resistant prostate cancer.
PMID 19047173·Cancer Res·2008
7-preclinical
Sintokamides A to E, chlorinated peptides from the sponge Dysidea sp. that inhibit transactivation of the N-terminus of the androgen receptor in prostate cancer cells.
PMID 18834139·Org Lett·2008
7-preclinical
ASAP1, a gene at 8q24, is associated with prostate cancer metastasis.
PMID 18519696·Cancer Res·2008
7-preclinical
14-3-3 sigma increases the transcriptional activity of the androgen receptor in the absence of androgens.
PMID 17433535·Cancer Lett·2007
8-other
Novel expressed sequences identified in a model of androgen independent prostate cancer.
PMID 17257419·BMC Genomics·2007
7-preclinical
Androgen receptor decoy molecules block the growth of prostate cancer.
PMID 17227854·Proc Natl Acad Sci U S A·2007
7-preclinical
Proteomic analyses to identify novel therapeutic targets for the treatment of advanced prostate cancer.
PMID 17205105·Cellscience·2006
8-other
Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approach.
PMID 17010196·BMC Genomics·2006
8-other
Identification of genes targeted by the androgen and PKA signaling pathways in prostate cancer cells.
PMID 16751804·Oncogene·2006
8-other
Amino-terminus domain of the androgen receptor as a molecular target to prevent the hormonal progression of prostate cancer.
PMID 16440300·J Cell Biochem·2006
6-review
A truncated isoform of TMEFF2 encodes a secreted protein in prostate cancer cells.
PMID 16439095·Genomics·2006
8-other
An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line.
PMID 16155594·Lab Invest·2005
7-preclinical
Identification of serum amyloid A as a biomarker to distinguish prostate cancer patients with bone lesions.
PMID 15695329·Clin Chem·2005
8-other
Development and characterization of efficient xenograft models for benign and malignant human prostate tissue.
PMID 15678503·Prostate·2005
7-preclinical
Cell lines used in prostate cancer research: a compendium of old and new lines--part 2.
PMID 15643173·J Urol·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1288 VALLEY FORGE RD., SUITE 72
VALLEY FORGE, PA 19482 - Phone
- (610) 933-9440
Quick Facts
- NPI
- 1588607196
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 43
- Publications
- 20
Are you this provider?
Claim Your Profile